• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压和非高血压受试者的血压水平与肾功能变化的关联。

The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects.

作者信息

Rosansky S J, Hoover D R, King L, Gibson J

机构信息

Medical Service, William Jennings Bryan Dorn Veterans Administration Hospital, Columbia 29201.

出版信息

Arch Intern Med. 1990 Oct;150(10):2073-6.

PMID:2222092
Abstract

We compared the changes in serum creatinine levels over time after a mean follow-up of 9.8 years in essential hypertensive (EH, n = 56) and control (n = 59) male veteran subjects. All subjects had normal serum creatinine levels (62 to 124 mumol/L) and "normal" urinalysis results on entry into the study. Subjects with comorbid renal diagnoses and diabetes mellitus were eliminated from the analysis. Although not statistically significant, the rate of change in the serum creatinine concentration over time was greater in the EH cohort compared with the control cohort (1.08 +/- 4.8 vs 0.027 +/- 3.5 mumol/L per year). The difference was especially marked in black EH subjects vs black control subjects (1.60 +/- 6.2 mumol/L per year vs -0.21 +/- 3.3 mumol/L per year). When age, race, body mass index, and a diagnosis of EH were entered into a logistic regression analysis, EH subjects had a statistically significantly greater rate of decline in renal function than did control subjects (1.5 +/- 8.3 mumol/L per year). When mean time-averaged systolic blood pressure for each subject was also included in the logistic regression analysis, only systolic time-averaged blood pressure was statistically significant (0.063 +/- 0.029 mumol/L per year). We conclude that in the absence of clinically detected parenchymal renal disease, EH subjects have a greater rate of decline in renal function than do nonhypertensive subjects. Time-averaged blood pressure is predictive of the change in serum creatinine concentration not only in EH subjects but also in nonhypertensive subjects. Thus, preservation of renal function may require a blood pressure lower than the currently accepted normotensive range.

摘要

我们比较了平均随访9.8年后,原发性高血压男性退伍军人受试者(EH,n = 56)和对照受试者(n = 59)血清肌酐水平随时间的变化。所有受试者在进入研究时血清肌酐水平正常(62至124μmol/L)且尿液分析结果“正常”。合并肾脏疾病诊断和糖尿病的受试者被排除在分析之外。尽管无统计学意义,但EH队列中血清肌酐浓度随时间的变化率高于对照队列(每年1.08±4.8 vs 0.027±3.5μmol/L)。这种差异在黑人EH受试者与黑人对照受试者中尤为明显(每年1.60±6.2μmol/L vs -0.21±3.3μmol/L)。当将年龄、种族、体重指数和EH诊断纳入逻辑回归分析时,EH受试者的肾功能下降率在统计学上显著高于对照受试者(每年1.5±8.3μmol/L)。当将每个受试者的平均时间平均收缩压也纳入逻辑回归分析时,只有时间平均收缩压具有统计学意义(每年0.063±0.029μmol/L)。我们得出结论,在没有临床检测到实质性肾脏疾病的情况下,EH受试者的肾功能下降率高于非高血压受试者。时间平均血压不仅可预测EH受试者血清肌酐浓度的变化,也可预测非高血压受试者的变化。因此,保护肾功能可能需要低于目前公认的正常血压范围的血压。

相似文献

1
The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects.高血压和非高血压受试者的血压水平与肾功能变化的关联。
Arch Intern Med. 1990 Oct;150(10):2073-6.
2
Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.肾移植患者因持续性高钙血症性甲状旁腺功能亢进接受甲状旁腺次全切除术后的血压和肾功能变化
Clin Nephrol. 1997 Apr;47(4):248-55.
3
Low-level lead exposure, renal function and blood pressure.低水平铅暴露、肾功能与血压。
Verh K Acad Geneeskd Belg. 1995;57(6):527-74.
4
Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.原发性高血压的长期肾功能:一项流行病学和病理生理学研究。
Scand J Urol Nephrol Suppl. 1999;199:1-36.
5
Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.肾活检时良性高血压性肾硬化症的临床特征。
Q J Med. 1993 Apr;86(4):271-5.
6
Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.高血压人群中的肾功能与心血管疾病:ERIC-HTA研究
J Hypertens. 2006 Apr;24(4):663-9. doi: 10.1097/01.hjh.0000217848.10831.5f.
7
[Possibilities of achieving target blood pressure in patients with essential hypertension in relation to renal functional status and age].[原发性高血压患者达到目标血压与肾功能状态及年龄的关系]
Ter Arkh. 2002;74(12):29-33.
8
[Effect of arterial pressure and age on renal function, The "Care for the Kidney" study].[动脉血压和年龄对肾功能的影响,“关爱肾脏”研究]
Nefrologia. 2003;23(2):137-44.
9
High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.与β2-肾上腺素能受体基因多态性相关的高血浆去甲肾上腺素水平可预测非肥胖正常血压个体未来的肾损伤。
Hypertens Res. 2007 Jun;30(6):503-11. doi: 10.1291/hypres.30.503.
10
"Benign" hypertensive nephrosclerosis.“良性”高血压性肾硬化症
QJM. 2007 Feb;100(2):113-9. doi: 10.1093/qjmed/hcl139. Epub 2007 Jan 23.

引用本文的文献

1
Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study.在肾小球滤过率正常的一般人群中,贫血和蛋白尿在随后肾功能恶化中的作用:一项基于社区的队列研究。
J Nephrol. 2019 Oct;32(5):775-781. doi: 10.1007/s40620-019-00605-2. Epub 2019 Apr 6.
2
Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study.通过基于人群的血压控制策略进行慢性肾脏病的一级预防:ARIC 研究。
J Clin Hypertens (Greenwich). 2018 Jun;20(6):1018-1026. doi: 10.1111/jch.13311. Epub 2018 May 23.
3
The renin-angiotensin system in blacks: active, passive, or what?
黑人的肾素-血管紧张素系统:主动、被动,还是其他情况?
Curr Hypertens Rep. 2003 Jun;5(3):225-30. doi: 10.1007/s11906-003-0025-x.
4
Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist.慢性肾功能不全的管理——非肾科医生和肾科医生的交织作用
J Natl Med Assoc. 2003 Jan;95(1):43-54.
5
Hypertension and its related factors in Taiwanese elderly people.台湾老年人的高血压及其相关因素。
Yale J Biol Med. 2001 Mar-Apr;74(2):89-94.
6
The kidney as a target of hypertension.肾脏作为高血压的靶器官。
Curr Hypertens Rep. 1999 Apr-May;1(2):164-9. doi: 10.1007/s11906-999-0014-9.
7
Renal protection and antihypertensive drugs: current status.肾脏保护与抗高血压药物:现状
Drugs. 1999 May;57(5):665-93. doi: 10.2165/00003495-199957050-00002.
8
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.加拿大高血压协会共识会议报告:3. 原发性高血压的药物治疗
CMAJ. 1993 Sep 1;149(5):575-84.
9
The kidney and arterial hypertension.肾脏与动脉高血压
Drugs. 1993;46 Suppl 2:108-12. doi: 10.2165/00003495-199300462-00019.